Latest news
Why Sarepta Therapeutics (SRPT) Is Up 12.9% After Cutting 2026 Guidance And Naming A New CEO - simplywall.stsimplywall.st · Mon, 10 Aug 2026 05:32:52 GMTSarepta Therapeutics (SRPT) Brings In Michael Severino As Chief Executive Officer - simplywall.stsimplywall.st · Sat, 08 Aug 2026 10:47:29 GMTSarepta Stock Dips After Hours: DMD Drug Blow And CEO Exit Eclipse Q4 Revenue Beat - StocktwitsStocktwits · Fri, 07 Aug 2026 17:26:02 GMTWeekly Recap: SRPT CEO equity grant and Morgan Stanley bullish on DMD catalysts - TradingViewTradingView · Mon, 03 Aug 2026 11:33:04 GMTSarepta Therapeutics, Inc. (SRPT) CEO gets 2,224,342 options, 756,104 RSUs - stocktitan.netstocktitan.net · Wed, 29 Jul 2026 07:00:00 GMTSarepta Therapeutics Appoints Michael Severino as CEO - The Globe and MailThe Globe and Mail · Tue, 28 Jul 2026 13:38:00 GMTSarepta Therapeutics (SRPT) Appoints New CEO, Shares Surge 7% - GuruFocusGuruFocus · Mon, 27 Jul 2026 16:28:23 GMTCambridge biotech taps external executive to lead after Elevidys controversy - The Business JournalsThe Business Journals · Mon, 27 Jul 2026 13:39:00 GMT